Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle‐Invasive Bladder Cancer in the United States
There was a shift in treatment modalities for MIBC, with increased utilization of RC with NAC. A decrease in post-surgery mortality rates may indicate improved outcomes, although the unmet need for NAC utilization requires further investigation.
Authors
- Mehmet Burcu (ORCID: https://orcid.org/0000-0003-4572-0987)
- M. Minhaj Siddiqui
- Nader Hanna
- B Davies-Teye (ORCID: https://orcid.org/0000-0001-8653-9338)
- Eberechukwu Onukwugha (ORCID: https://orcid.org/0000-0001-8547-1810)
- Xiao Zhang (ORCID: https://orcid.org/0000-0002-2932-5875)
- Abree Johnson
Institutions
- University of Maryland, Baltimore (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/cam4.70644
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Merck Sharp and Dohme